Iron Absorption From Lipid-Based Nutrient Supplements
Dietary Iron Absorption From Lipid-Based Nutrient Supplements - A Pilot Study
1 other identifier
observational
30
1 country
1
Brief Summary
The overall objective of this study is to determine dietary iron absorption from lipid-based nutrient supplements (LNS) in apparently healthy and undernourished children. This case-control study will recruit apparently healthy children and children with uncomplicated undernutrition (age 1-3 years, n=15/group) from Msambweni and the surrounding rural communities in Kwale County, Kenya. At the baseline visit (day 0), participants will be provided with an LNS labeled with a stable iron isotope (57-Fe). Participants will return to the hospital 14 days later (day 14) for a blood draw. Blood collected on day 14 will be used to measure iron isotope incorporation into red blood cells. Blood collected at screening will be used to measure indicators of anemia, iron status, hepcidin, and inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2025
CompletedFirst Posted
Study publicly available on registry
March 11, 2025
CompletedStudy Start
First participant enrolled
March 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedDecember 5, 2025
August 1, 2025
11 months
February 27, 2025
December 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Dietary iron absorption
Isotope incorporation into RBCs on day 14
Secondary Outcomes (7)
Hemoglobin
Measured at screening
Serum ferritin
Measured at screening
Soluble transferrin receptor
Measured at screening
Transferrin saturation
Measured at screening
Hepcidin
Measured at screening
- +2 more secondary outcomes
Study Arms (2)
Apparently Healthy
Undernourished
Interventions
LNS labeled with a stable iron isotope
Eligibility Criteria
Participants will be recruited from Msambweni and the surrounding rural communities in Kwale County, Kenya.
You may qualify if:
- Children age 1-3 years on day of screening visit
- Hemoglobin 8-11 g/dL on day of screening visit
- Undernourished \[length/height-for-age z-score (HAZ), weight-for-age z-score (WAZ), and/or weight-for-height/length z-score (WHZ) \< -2\] OR apparently healthy (HAZ, WAZ, and/or WHZ ≥ -1)
You may not qualify if:
- Severe acute malnutrition (WHZ \< -3) with no appetite
- Serious medical condition or other chronic disease besides undernutrition (e.g., HIV+, severe pneumonia, malaria)
- Peanut allergy or other allergy that prevents consumption of the LNS
- Plans to move away from the study location during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Msambweni County Referral Hospital
Msambweni, Kenya
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen Hennigar, PhD
Pennington Biomedical Research Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 27, 2025
First Posted
March 11, 2025
Study Start
March 25, 2025
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
December 5, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share